Telangana has secured an investment of one billion US dollars from US pharma major Eli Lilly to expand its manufacturing and global medicine supply capacity in Hyderabad. The announcement has been made after a delegation from the company met Telangana Chief Minister A Revanth Reddy and State Industries Minister D Sridhar Babu in Hyderabad yesterday. The company inaugurated its Global Capability Centre (GCC) in Hyderabad in August this year.

An official release stated that despite strong interest from several other states, Eli Lilly chose Telangana owing to the favourable ecosystem, availability of skilled manpower, infrastructure, and proactive government support. It further said that with the new facilities, Eli Lilly is set to manufacture in Telangana and supply globally. The One-billion-dollar investment by Eli Lilly reflects the company’s interest in Telangana beyond its GCC operations and focuses on developing new medicines to treat diabetes and obesity, Alzheimer’s disease, cancer and autoimmune conditions.